130 related articles for article (PubMed ID: 15854047)
21. Osteopontin stimulates invasion of NCI-h295 cells but is not associated with survival in adrenocortical carcinoma.
Weismann D; Briese J; Niemann J; Grüneberger M; Adam P; Hahner S; Johanssen S; Liu W; Ezzat S; Saeger W; Bamberger AM; Fassnacht M; Schulte HM; Asa SL; Allolio B; Bamberger CM
J Pathol; 2009 Jun; 218(2):232-40. PubMed ID: 19326399
[TBL] [Abstract][Full Text] [Related]
22. Interferon-induced transmembrane 3 binds osteopontin in vitro: expressed in vivo IFITM3 reduced OPN expression.
El-Tanani MK; Jin D; Campbell FC; Johnston PG
Oncogene; 2010 Feb; 29(5):752-62. PubMed ID: 19901966
[TBL] [Abstract][Full Text] [Related]
23. Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma.
Massi D; Naldini A; Ardinghi C; Carraro F; Franchi A; Paglierani M; Tarantini F; Ketabchi S; Cirino G; Hollenberg MD; Geppetti P; Santucci M
Hum Pathol; 2005 Jun; 36(6):676-85. PubMed ID: 16021575
[TBL] [Abstract][Full Text] [Related]
24. Loss of XRCC1 confers a metastatic phenotype to melanoma cells and is associated with poor survival in patients with melanoma.
Bhandaru M; Martinka M; Li G; Rotte A
Pigment Cell Melanoma Res; 2014 May; 27(3):366-75. PubMed ID: 24410901
[TBL] [Abstract][Full Text] [Related]
25. Microarray analysis of human milk cells: persistent high expression of osteopontin during the lactation period.
Nagatomo T; Ohga S; Takada H; Nomura A; Hikino S; Imura M; Ohshima K; Hara T
Clin Exp Immunol; 2004 Oct; 138(1):47-53. PubMed ID: 15373904
[TBL] [Abstract][Full Text] [Related]
26. Single cell analysis of intracellular osteopontin in osteogenic cultures of fetal rat calvarial cells.
Zohar R; Lee W; Arora P; Cheifetz S; McCulloch C; Sodek J
J Cell Physiol; 1997 Jan; 170(1):88-100. PubMed ID: 9012788
[TBL] [Abstract][Full Text] [Related]
27. Loss of EphB6 expression in metastatic melanoma.
Hafner C; Bataille F; Meyer S; Becker B; Roesch A; Landthaler M; Vogt T
Int J Oncol; 2003 Dec; 23(6):1553-9. PubMed ID: 14612926
[TBL] [Abstract][Full Text] [Related]
28. Lentiviral-mediated siRNA targeted against osteopontin suppresses the growth and metastasis of gastric cancer cells.
Wang ZM; Cui YH; Li W; Chen SY; Liu TS
Oncol Rep; 2011 Apr; 25(4):997-1003. PubMed ID: 21286666
[TBL] [Abstract][Full Text] [Related]
29. A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis.
Alonso SR; Tracey L; Ortiz P; Pérez-Gómez B; Palacios J; Pollán M; Linares J; Serrano S; Sáez-Castillo AI; Sánchez L; Pajares R; Sánchez-Aguilera A; Artiga MJ; Piris MA; Rodríguez-Peralto JL
Cancer Res; 2007 Apr; 67(7):3450-60. PubMed ID: 17409456
[TBL] [Abstract][Full Text] [Related]
30. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
Mi Z; Guo H; Wai PY; Gao C; Kuo PC
Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180
[TBL] [Abstract][Full Text] [Related]
31. Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas.
Tuck AB; O'Malley FP; Singhal H; Tonkin KS; Harris JF; Bautista D; Chambers AF
Arch Pathol Lab Med; 1997 Jun; 121(6):578-84. PubMed ID: 9199622
[TBL] [Abstract][Full Text] [Related]
32. RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas.
Fagiani E; Giardina G; Luzi L; Cesaroni M; Quarto M; Capra M; Germano G; Bono M; Capillo M; Pelicci P; Lanfrancone L
Cancer Res; 2007 Apr; 67(7):3064-73. PubMed ID: 17409413
[TBL] [Abstract][Full Text] [Related]
33. Osteopontin induces multiple changes in gene expression that reflect the six "hallmarks of cancer" in a model of breast cancer progression.
Cook AC; Tuck AB; McCarthy S; Turner JG; Irby RB; Bloom GC; Yeatman TJ; Chambers AF
Mol Carcinog; 2005 Aug; 43(4):225-36. PubMed ID: 15864800
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
[TBL] [Abstract][Full Text] [Related]
35. Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness.
Guarino V; Faviana P; Salvatore G; Castellone MD; Cirafici AM; De Falco V; Celetti A; Giannini R; Basolo F; Melillo RM; Santoro M
J Clin Endocrinol Metab; 2005 Sep; 90(9):5270-8. PubMed ID: 15998773
[TBL] [Abstract][Full Text] [Related]
36. Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1.
Metge BJ; Liu S; Riker AI; Fodstad O; Samant RS; Shevde LA
Oncology; 2010; 78(1):75-86. PubMed ID: 20215788
[TBL] [Abstract][Full Text] [Related]
37. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model.
Oates AJ; Barraclough R; Rudland PS
Oncogene; 1996 Jul; 13(1):97-104. PubMed ID: 8700559
[TBL] [Abstract][Full Text] [Related]
38. A small interfering RNA targeting osteopontin as gastric cancer therapeutics.
Gong M; Lu Z; Fang G; Bi J; Xue X
Cancer Lett; 2008 Dec; 272(1):148-59. PubMed ID: 18694621
[TBL] [Abstract][Full Text] [Related]
39. [Interference of osteopontin expression inhibits the invasion and metastasis of human hepatocellular carcinoma cell lines].
Lin F; Li YY; Xia JT; Wen MJ; Lai YY; Cai WS; Wu ZF; Fan SF
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):422-5. PubMed ID: 19567019
[TBL] [Abstract][Full Text] [Related]
40. PUMA expression is significantly reduced in human cutaneous melanomas.
Karst AM; Dai DL; Martinka M; Li G
Oncogene; 2005 Feb; 24(6):1111-6. PubMed ID: 15690057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
